145 Assessing the Impact of an Inpatient Anticoagulation Stewardship Program

Introduction: The 2019 Joint Commission National Patient Safety Goal #3 emphasizes reducing harm associated with anticoagulant therapy. To address this, an inpatient anticoagulation stewardship program was implemented in January 2021. This study evaluates the program's impact on reducing medication errors, pharmacist interventions, and 30-day readmissions related to bleeding or clotting events. The primary objective was to assess the program's effect on medication error reduction. Secondary objectives included analysis of pharmacist interventions and 30-day readmission rates for bleeding or clotting.